GeneDx Holdings Corp. (WGS) Financials

WGS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 481.5 million 237.3 million
March 31, 2026 506.3 million 252.2 million
Dec. 31, 2025 570.2 million 262.0 million
Sept. 30, 2025 493.9 million 201.6 million

WGS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -39.1 million 6.3 million
March 31, 2026 -38.9 million 9.0 million
Dec. 31, 2025 -7.4 million 9.8 million
Sept. 30, 2025 9.6 million 10.6 million

WGS Net Income

No data available :(

WGS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 132.5 million 96.8 million 64.9 million
March 31, 2026 170.7 million 96.7 million 71.5 million
Dec. 31, 2025 171.3 million 87.0 million 56.0 million
Sept. 30, 2025 155.1 million 51.6 million 61.6 million

WGS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 29.7 million
March 31, 2026 29.3 million
Dec. 31, 2025 26.9 million
Sept. 30, 2025 28.8 million

WGS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 10.1 million 19.7 million 76.0 million -
March 31, 2026 6.5 million 19.8 million 74.6 million -
Dec. 31, 2025 4.3 million 24.0 million 74.4 million 27.1 million
Sept. 30, 2025 6.2 million 19.8 million 67.2 million 23.5 million

WGS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 114.4 million 36.2 million
March 31, 2026 102.3 million 34.0 million
Dec. 31, 2025 121.0 million 42.1 million
Sept. 30, 2025 116.7 million 32.2 million

WGS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

WGS

Price: $85.99

52 week price:
32.21
170.87

Earnings Per Share: -3.63 USD

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Market Capitalization: 2.6 billion

Links: